Hillhouse Capital-backed medical device company Peijia Medical has raised HK$2.34bn (US$302m) in a strongly supported initial public offering on the Hong Kong Stock Exchange. It sold 152.5 million shares or 25% of the expanded share base, at HK$15.36 per share which gives the company a market cap of US$1.2bn. There is also a greenshoe option…
Home Healthcare Markets International Business Hong Kong: Peijia Medical raises US$302m in Hong Kong IPO